KDM6B Counteracts EZH2-Mediated Suppression of <i>IGFBP5</i> to Confer Resistance to PI3K/AKT Inhibitor Treatment in Breast Cancer
Crossref DOI link: https://doi.org/10.1158/1535-7163.MCT-17-0802
Published Online: 2018-09-04
Published Print: 2018-09-01
Update policy: https://doi.org/10.1158/crossmark_policy
Wang, Wenyu
Lim, Keng Gat
Feng, Min
Bao, Yi
Lee, Puay Leng
Cai, Yu
Chen, Yufeng
Zhang, Hao
Marzese, Diego
Hoon, Dave S.B.
Yu, Qiang
Funding for this research was provided by:
National Medical Research Council (OFIRG16may081)